Sweden MPA News alt

Fluticasone Inhalation Spray Shortage Ends for Animals

Läkemedelsverket (Swedish Medicines Agency) announced on 20 April 2026 that the long-standing shortage of fluticasone inhalation spray for animals is over. Supply is now assessed as sufficient, and the previous recommendation to veterinary healthcare to restrict prescribing no longer applies. The agency states that new reported sales suspensions may arise and can be tracked via its searchable service updated daily.

Sweden Updates National Knowledge Support for Pediatric Medication Management

Läkemedelsverket (Swedish MPA) has updated its national knowledge support framework for pediatric medication management, originally developed by an expert group including Centrum för barn och läkemedel (CBOL). The update strengthens several clinical areas including off-label use guidance, adolescent healthcare, child and adolescent psychiatry treatment, self-harm risk considerations, and treatment follow-up protocols. The guidance aims to ensure equitable access to medicines for children and improve patient safety outcomes across primary and specialized care settings.

Stabil tillgång till läkemedel men ökad beredskap i ljuset av omvärldsläget

Läkemedelsverket (Swedish Medical Products Agency) has assessed that Sweden's pharmaceutical supply is in normal mode with no current disruptions linked to the Middle East conflict. While risks exist on medium to long-term horizons — including higher transport costs, energy prices, and global supply chain disruptions — the agency reports no present shortages. The MPA strengthens preparedness through the Aktörsgemensamt dialogmöte för läkemedelstillgänglighet (ADL) forum, maintaining ongoing dialogue with industry and other actors, and coordinates through EU and Nordic frameworks where the overall picture is also one of stable supply.